Donaldson Elects Chief Operating Officer Richard Lewis to Succeed Tod Carpenter as President and CEO as Part of Planned Succession
DCIMINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI) (Donaldson or the Company), a global leader in technology-led filtration products and solutions, announced that the Company’s board of directors has elected chief operating officer Richard Lewis as president and chief executive officer, effective March 2, 2026. Lewis will succeed Tod Carpenter, who will transition to executive chairman after a career spanning 30 years at the Company, including the past 11 years as president and c
Donaldson Company Declares Quarterly Cash Dividend
DCIMINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI) today announced its Board of Directors declared a regular cash dividend of 30.0 cents per share. The dividend is payable February 27th, 2026, to shareholders of record on February 12th, 2026. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index and calendar year 2025 marked the 30th consecutive year of annual dividend increases. The Company has paid a cash dividend every quarter for 70 years. About Donaldson
Donaldson Company to Present at the Jefferies 2025 Industrials and Morgan Stanley 13th Annual Laguna Conferences
DCI(NYSE:DCI) MINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced that Tod Carpenter, chairman, president, and chief executive officer will present at the Jefferies 2025 Industrials Conference on Wednesday, September 3, 2025, beginning at 9:30 a.m. ET. Brad Pogalz, chief financial officer, will present at the Morgan Stanley 13th Annual Laguna Conference on Wednesday, September 10, 2025, beginning at 4
Donaldson Reports Record Fourth Quarter; Full-Year 2025 Sales and Earnings
DCIMINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI) (Donaldson or the Company), a global leader in technology-led filtration products and solutions, today reported fiscal 2025 GAAP net earnings of $114.3 million in the fourth quarter and $367.0 million for the full year, compared with $109.7 million and $414.0 million, respectively, in fiscal 2024. Fiscal 2025 GAAP EPS were $0.97 in the fourth quarter and $3.05 for the full year, compared with $0.90 and $3.38, respectively, in the
Morgan Stanley Maintains Underweight on Donaldson, Raises Price Target to $69
DCIBaird Maintains Outperform on Donaldson, Raises Price Target to $78
DCIDonaldson CEO Says Tariff Impact Is Immaterial, Raises Annual Profit Outlook
DCIDonaldson Company (NYSE: DCI) reported its Q3 FY25 results with sales rising 1.3% Y/Y to $940.1M, missing consensus. GAAP net earnings decreased significantly due to non-recurring charges. The company revised its FY25 guidance for adjusted EPS and sales growth.
Donaldson Revised Guidance For FY25 Sales To Be Up 1% To 3% (From Flat To Up 4% Earlier)
DCIDonaldson Raises FY2025 Adj EPS Guidance from $3.60-$3.68 to $3.64-$3.70 vs $3.60 Est
DCIDonaldson Q3 Adj. EPS $0.99, Inline, Sales $940.10M Miss $943.02M Estimate
DCIDonaldson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
DCIDonaldson Appoints Richard Lewis Chief Operating Officer, Effective August 1, 2025
DCIDonaldson Earnings Preview
DCIDonaldson Company Increases Quarterly Cash Dividend From $0.27 To $0.30 Per Share
DCIDonaldson Co's Thomas R. Scalf To Retire As President On August 1, 2025
DCIDonaldson Life Sciences' Univercells Technologies Announces The Launch Of Its scale-X Nitro Controller
DCIIsolere Bio By Donaldson Announces Availability Of Manufacturing-grade IsoTag AAV Reagent For Purification Of AAV Vectors
DCIPrice Over Earnings Overview: Donaldson
DCIStifel Maintains Hold on Donaldson, Lowers Price Target to $63
DCIGinkgo Bioworks Works With Partners On ARPA-H Project To Stabilize Pharmaceutical Supply Chains
DCIDonaldson Q2 Earnings Miss: Aftermarket And Life Sciences Segments Shine Amid Revenue Dip
DCIDonaldson Co., reported Q2 results with sales down 0.8%. Adjusted EPS of $0.83 missed consensus of $0.85. FY25 guidance revised.
Donaldson Revised Guidance For FY25 Adj. EPS To $3.60-$3.68 (From $3.56-$3.72 Earlier) Vs. Est. $3.63; Sales To Be Flat To Up 4% (From Increase 2%-6% YoY Earlier)
DCIDonaldson Q2 2025 Adj EPS $0.83 Misses $0.85 Estimate, Sales $870.00M Miss $908.33M Estimate
DCI